Table of Contents Author Guidelines Submit a Manuscript
Depression Research and Treatment
Volume 2011, Article ID 893905, 7 pages
http://dx.doi.org/10.1155/2011/893905
Review Article

Dysthymia and Apathy: Diagnosis and Treatment

1Department of Psychiatry, Nagata Hospital, 5173 Goji-cho, Miyakonojo-shi, Miyazaki 885-0084, Japan
2Department of Neuropsychiatry, Showa University School of Medicine, 6-11-11 Kita-Karasuyama, Setagaya-ku, Tokyo 157-8577, Japan
3Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan

Received 6 December 2010; Accepted 24 April 2011

Academic Editor: Mathias Berger

Copyright © 2011 Junko Ishizaki and Masaru Mimura. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Weissman, P. J. Leaf, M. L. Bruce, and L. Florio, “The epidemiology of dystmia in five communities: rates, risks, comorbidity, and treatment,” The American Journal of Psychiatry, vol. 145, no. 7, pp. 815–819, 1988. View at Google Scholar · View at Scopus
  2. R. C. Kessler, K. A. McGonagle, S. Zhao et al., “Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey,” Archives of General Psychiatry, vol. 51, no. 1, pp. 8–19, 1994. View at Google Scholar · View at Scopus
  3. J. C. Markowitz, M. E. Moran, J. H. Kocsis, and A. J. Frances, “Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients,” Journal of Affective Disorders, vol. 24, no. 2, pp. 63–71, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. W. E. Broadhead, D. G. Blazer, L. K. George, and C. K. Tse, “Depression, disability days, and days lost from work in a prospective epidemiologic survey,” Journal of the American Medical Association, vol. 264, no. 19, pp. 2524–2528, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Text Revision, 4th edition, 2000.
  6. N. Brunello, H. Akiskal, P. Boyer et al., “Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas,” Journal of Affective Disorders, vol. 52, no. 1–3, pp. 275–290, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Kovacs, H. S. Akiskal, C. Gatsonis, and P. L. Parrone, “Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder,” Archives of General Psychiatry, vol. 51, no. 5, pp. 365–374, 1994. View at Google Scholar
  8. M. B. Keller, D. N. Klein, R. M. A. Hirschfeld et al., “Results of the DSM-IV mood disorders field trial,” The American Journal of Psychiatry, vol. 152, no. 6, pp. 843–849, 1995. View at Google Scholar · View at Scopus
  9. D. N. Klein, J. E. Schwartz, S. Rose, and J. B. Leader, “Five-year course and outcome of dysthymic disorder: a prospective, naturalistic follow-up study,” The American Journal of Psychiatry, vol. 157, no. 6, pp. 931–939, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. D. N. Klein, S. A. Shankman, and S. Rose, “Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression,” The American Journal of Psychiatry, vol. 163, no. 5, pp. 872–880, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. S. Kwon, Y. M. Kim, C. G. Chang et al., “Three-year follow-up of women with the sole diagnosis of depressive personality disorder: subsequent development of dysthymia and major depression,” The American Journal of Psychiatry, vol. 157, no. 12, pp. 1966–1972, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. D. P. Devanand, M. S. Nobler, J. Cheng et al., “Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder,” The American Journal of Geriatric Psychiatry, vol. 13, no. 1, pp. 59–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Vanelle, D. Attar-Levy, M. F. Poirier, M. Bouhassira, P. Blin, and J. P. Olié, “Controlled efficacy study of fluoxetine in dysthymia,” The British Journal of Psychiatry, vol. 170, pp. 345–350, 1997. View at Google Scholar · View at Scopus
  14. M. E. Thase, M. Fava, U. Halbreich et al., “A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia,” Archives of General Psychiatry, vol. 53, no. 9, pp. 777–784, 1996. View at Google Scholar · View at Scopus
  15. J. H. Kocsis, S. Zisook, J. Davidson et al., “Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes,” The American Journal of Psychiatry, vol. 154, no. 3, pp. 390–395, 1997. View at Google Scholar · View at Scopus
  16. J. W. Williams Jr., J. Barrett, T. Oxman et al., “Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults,” Journal of the American Medical Association, vol. 284, no. 12, pp. 1519–1526, 2000. View at Google Scholar · View at Scopus
  17. J. E. Barrett, J. W. Williams Jr., T. E. Oxman et al., “Treatment of dysthymia and minor depression in primary care: a ramdomized trial in patients aged 18 to 59 years,” Journal of Family Practice, vol. 50, no. 5, pp. 405–412, 2001. View at Google Scholar · View at Scopus
  18. A. V. Ravindran, J. D. Guelfi, R. M. Lane, and G. B. Cassano, “Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression,” Journal of Clinical Psychiatry, vol. 61, no. 11, pp. 821–827, 2000. View at Google Scholar · View at Scopus
  19. R. F. Haykal and H. S. Akiskal, “The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management,” Journal of Clinical Psychiatry, vol. 60, no. 8, pp. 508–518, 1999. View at Google Scholar · View at Scopus
  20. D. J. Hellerstein, S. T. Batchelder, S. A. Little, M. J. Fedak, D. Kreditor, and J. Rosenthal, “Venlafaxine in the treatment of dysthymia: an open-label study,” Journal of Clinical Psychiatry, vol. 60, no. 12, pp. 845–849, 1999. View at Google Scholar · View at Scopus
  21. A. V. Ravindran, Y. Charbonneau, M. D. Zaharia, K. Al-Zaid, A. Wiens, and H. Anisman, “Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia,” Journal of Psychiatry and Neuroscience, vol. 23, no. 5, pp. 288–292, 1998. View at Google Scholar · View at Scopus
  22. M. S. De Lima and J. Moncrieff, “Drugs versus placebo for dysthymia,” Cochrane Database of Systematic Reviews, no. 4, 2000. View at Google Scholar · View at Scopus
  23. M. S. De Lima and M. Hotopf, “A comparison of active drugs for the treatment of dysthymia,” Cochrane Database of Systematic Reviews, no. 3, 2003. View at Google Scholar · View at Scopus
  24. K. Komossa, A. M. Depping, A. Gaudchau, W. Kissling, and S. Leucht, “Second-generation antipsychotics for major depressive disorder and dysthymia,” Cochrane Database of Systematic Reviews, no. 12, 2010. View at Google Scholar
  25. J. P. McCullough, “Psychotherapy for dysthymia: a naturalistic study of ten patients,” Journal of Nervous and Mental Disease, vol. 179, no. 12, pp. 734–740, 1991. View at Google Scholar · View at Scopus
  26. M. B. Keller, J. P. McCullough, D. N. Klein et al., “A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression,” The New England Journal of Medicine, vol. 342, no. 20, pp. 1462–1470, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. R. S. Marin, “Apathy: a neuropsychiatric syndrome,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 3, no. 3, pp. 243–254, 1991. View at Google Scholar · View at Scopus
  28. S. E. Starkstein, H. S. Mayberg, T. J. Preziosi, P. Andrezejewski, R. Leiguarda, and R. G. Robinson, “Reliability, validity, and clinical correlates of apathy in Parkinson's disease,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 4, no. 2, pp. 134–139, 1992. View at Google Scholar · View at Scopus
  29. R. Levy and B. Dubois, “Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits,” Cerebral Cortex, vol. 16, no. 7, pp. 916–928, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. S. E. Starkstein, G. Petracca, E. Chemerinski, and J. Kremer, “Syndromic validity of apathy in Alzheimer's disease,” The American Journal of Psychiatry, vol. 158, no. 6, pp. 872–877, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. R. S. Marin, R. C. Biedrzycki, and S. Firinciogullari, “Reliability and validity of the apathy evaluation scale,” Psychiatry Research, vol. 38, no. 2, pp. 143–162, 1991. View at Publisher · View at Google Scholar · View at Scopus
  32. T. M. Tattan and F. H. Creed, “Negative symptoms of schizophrenia and compliance with medication,” Schizophrenia Bulletin, vol. 27, no. 1, pp. 149–155, 2001. View at Google Scholar · View at Scopus
  33. R. M. Roth, L. A. Flashman, A. J. Saykin, T. W. McAllister, and R. Vidaver, “Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits,” The American Journal of Psychiatry, vol. 161, no. 1, pp. 157–159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. S. E. Starkstein, J. P. Fedoroff, T. R. Price, R. Leiguarda, and R. G. Robinson, “Apathy following cerebrovascular lesions,” Stroke, vol. 24, no. 11, pp. 1625–1630, 1993. View at Google Scholar · View at Scopus
  35. A. Withall, H. Brodaty, A. Altendorf, and P. S. Sachdev, “A longitudinal study examining the independence of apathy and depression after stroke: the Sydney Stroke Study,” International Psychogeriatrics, vol. 23, no. 2, pp. 264–273, 2011. View at Google Scholar
  36. R. Marin and S. Chakravorty, “Disorders of diminished motivation,” in Textbook of Traumatic Brain Injury, J. M. Silver, T. W. McAllister, and S. C. Yudofsky, Eds., pp. 337–352, American Psychiatric, Arlington, Va, USA, 2005. View at Google Scholar
  37. D. Aarsland, J. P. Larsen, N. G. Lim et al., “Range of neuropsychiatric disturbances in patients with Parkinson's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 67, no. 4, pp. 492–496, 1999. View at Google Scholar · View at Scopus
  38. D. Aarsland, I. Litvan, and J. P. Larsen, “Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 13, no. 1, pp. 42–49, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. J. M. Hamilton, D. P. Salmon, J. Corey-Bloom et al., “Behavioural abnormalities contribute to functional decline in Huntington's disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 74, no. 1, pp. 120–122, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. J. C. Thompson, J. S. Snowden, D. Craufurd, and D. Neary, “Behavior in Huntington's disease: dissociating cognition-based and mood-based changes,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 14, no. 1, pp. 37–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. T. W. Chow, M. A. Binns, J. L. Cummings et al., “Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type,” Archives of Neurology, vol. 66, no. 7, pp. 888–893, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. M. L. Levy, B. L. Miller, J. L. Cummings, L. A. Fairbanks, and A. Craig, “Alzheimer disease and frontotemporal dementias: behavioral distinctions,” Archives of Neurology, vol. 53, no. 7, pp. 687–690, 1996. View at Google Scholar · View at Scopus
  43. S. S. Staekenborg, T. Su, E. C. van Straaten et al., “Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 81, no. 5, pp. 547–551, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. J. G. Rabkin, S. J. Ferrando, W. van Gorp, R. Rieppi, M. McElhiney, and M. Sewell, “Relationships among apathy, depression, and cognitive impairment in HIV/AIDS,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 12, no. 4, pp. 451–457, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. R. S. Marin, S. Firinciogullari, and R. C. Biedrzycki, “Group differences in the relationship between apathy and depression,” Journal of Nervous and Mental Disease, vol. 182, no. 4, pp. 235–239, 1994. View at Google Scholar · View at Scopus
  46. M. Hamilton, “A rating scale for depression,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 23, pp. 56–62, 1960. View at Google Scholar · View at Scopus
  47. I. Litvan, M. S. Mega, J. L. Cummings, and L. Fairbanks, “Neuropsychiatric aspects of progressive supranuclear palsy,” Neurology, vol. 47, no. 5, pp. 1184–1189, 1996. View at Google Scholar · View at Scopus
  48. M. F. Folstein, S. E. Folstein, and P. R. McHugh, “Mini-mental state. A practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Publisher · View at Google Scholar · View at Scopus
  49. J. R. Lipsey, R. G. Robinson, G. D. Pearlson, K. Rao, and T. R. Price, “Dexamethasone suppression test and mood following stroke,” The American Journal of Psychiatry, vol. 142, no. 3, pp. 318–323, 1985. View at Google Scholar · View at Scopus
  50. K. Bolla-Wilson, R. G. Robinson, S. E. Starkstein, J. Boston, and T. R. Price, “Lateralization of dementia of depression in stroke patients,” The American Journal of Psychiatry, vol. 146, no. 5, pp. 627–634, 1989. View at Google Scholar · View at Scopus
  51. P. J. Eslinger and A. R. Damasio, “Severe disturbance of higher cognition after bilateral frontal lobe ablation: patient EVR,” Neurology, vol. 35, no. 12, pp. 1731–1741, 1985. View at Google Scholar · View at Scopus
  52. D. T. Stuss, R. Van Reekum, and K. J. Murphy, “Differentiation of states and causes of apathy,” in Neuropsychology of Emotion, J. C. Borod, Ed., pp. 340–363, Oxford University Press, Oxford, UK, 2000. View at Google Scholar
  53. M. F. Mendez, N. L. Adams, and K. S. Lewandowski, “Neurobehavioral changes associated with caudate lesions,” Neurology, vol. 39, no. 3, pp. 349–354, 1989. View at Google Scholar · View at Scopus
  54. K. P. Bhatia and C. D. Marsden, “The behavioural and motor consequences of focal lesions of the basal ganglia in man,” Brain, vol. 117, no. 4, pp. 859–876, 1994. View at Google Scholar · View at Scopus
  55. S. Engelborghs, P. Marien, B. A. Pickut, S. Verstraeten, and P. P. De Deyn, “Loss of psychic self-activation after paramedian bithalamic infarction,” Stroke, vol. 31, no. 7, pp. 1762–1765, 2000. View at Google Scholar · View at Scopus
  56. F. Ghika-Schmid and J. Bogousslavsky, “The acute behavioral syndrome of anterior thalamic infarction: a prospective study of 12 cases,” Annals of Neurology, vol. 48, no. 2, pp. 220–227, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. S. E. Starkstein and R. G. Robinson, “Depression in cerebrovascular disease,” in Depression in Neurologic Disease, S. E. Starkstein and R. G. Robinson, Eds., pp. 28–49, Johns Hopkins University Press, Baltimore, Md, USA, 1993. View at Google Scholar
  58. N. Wongpakaran, R. Van Reekum, T. Wongpakaran, and D. Clarke, “Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study,” Annals of General Psychiatry, vol. 5, supplement 1, p. S83, 2006. View at Google Scholar
  59. G. Toyoda, R. Saika, A. Aoyama et al., “The effect of cilostazol on apathy after cerebral infarction,” Japanese Journal of Stroke, vol. 33, pp. 182–184, 2011. View at Google Scholar
  60. A. Lane-Brown and R. Tate, “Interventions for apathy after traumatic brain injury,” Cochrane Database of Systematic Reviews, no. 2, 2009. View at Google Scholar · View at Scopus
  61. Y. X. Niu, J. P. Tan, J. Q. Guan, and L. N. Wang, “Cognitive stimulation therapy in the treatment of neuropsychiatric symptoms in Alzheimer's disease: a randomized controlled trial,” Clinical Rehabilitation, vol. 12, pp. 1102–1111, 2010. View at Google Scholar